US FDA Approves Pulmonary Fibrosis Drug Developed by Alembic Pharmaceuticals

The company ‘Alembic Pharmaceuticals’ has announced that, the company has now received the final approval from the Food and Drug Administration (FDA) of the United States for the company’s Abbreviated New Drug Application (ANDA) for the pirfenidone tablets used for treating Pulmonary Fibrosis. The approved ANDA has been therapeutically equivalent to the reference that has […]

Continue Reading